Statistical analysis of COPD exacerbations

European Respiratory Journal

Volumn 32, Issue 5, 2008, Pages 1421-1422

  Keene, O N ^a   Calverley, P M A ^b   Jones, P W ^c   Vestbo, J ^d   Anderson, J A ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DISEASE EXACERBATION; HUMAN; LETTER; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADRENAL CORTEX HORMONES; CLINICAL TRIALS AS TOPIC; DATA INTERPRETATION, STATISTICAL; FOLLOW-UP STUDIES; HUMANS; PATIENT COMPLIANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESEARCH DESIGN; STATISTICS AS TOPIC; TREATMENT OUTCOME;

EID: 58849130162     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00123408     Document Type: Letter

References (4)

1. Suissa S. Exacerbations, intent-to-treat analyses in randomised trials. Eur Respir J 2008; 32: 1117-1118.
2. Moher D, Schulz KF, Altman D, for the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001; 285: 1987-1991.
3. Altman DG, Schulz KF, Moher D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001; 134: 663-694.
4. Pocock SJ. Clinical Trials: a Practical Approach. Chichester, Wiley, 1983; p. 81.